High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates - Wikidata - wikimedia - TriplyDB

High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates

High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates

http://www.wikidata.org/entity/Q33798166

about

Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.Whole-genome sequencing to control antimicrobial resistance Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012 Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical Isolates.Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.Comprehensive Whole-Genome Sequencing and Reporting of Drug Resistance Profiles on Clinical Cases of Mycobacterium tuberculosis in New York State.Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis.Genomic Analysis of the Evolution of Fluoroquinolone Resistance in Mycobacterium tuberculosis Prior to Tuberculosis Diagnosis.Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus.Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays.Antimicrobial heteroresistance: an emerging field in need of clarity.In vivo Mycobacterium tuberculosis fluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests.Prevalence of mutations conferring resistance among multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in China.Highly Sensitive Detection of Isoniazid Heteroresistance in Mycobacterium tuberculosis by DeepMelt Assay.Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.Signatures of Selection at Drug Resistance Loci in Mycobacterium tuberculosis.

P2860

Q30252340-DF23E9E2-ECE9-4620-B2BB-05E7C0C7A704 Q34142073-9CD0C04A-B624-4549-9335-360B56AF83E7 Q35105829-CA1A2319-C7ED-43DC-B925-B7A7DA615655 Q35644365-574DCD43-605E-4A0E-A8A3-D064A583CF91 Q35693044-6704D032-61E7-4185-9F0D-6CA41509ED37 Q35757559-996183DD-1FB8-4024-A7B2-13E8BC3A194C Q35960685-7F16929A-38AB-4F2D-9B02-7AA3B4CCC2AC Q36318992-90EFCF86-CF44-48E9-8E1B-EC4F7D1DAF13 Q36337329-4586851B-6613-458E-A03B-B0CC443C6B2A Q36794791-15489794-7D95-4758-8FE0-F1D6CAE918E9 Q37358635-B2043B8F-1A08-4E3B-8842-5F6AB3A9F1E4 Q37611856-FE49EA8E-39FC-4E2E-BEDF-71AFA1BFBBC4 Q37720805-9B783F1F-CC26-4EA7-96E0-2E05EB4B5EC5 Q38310639-62CEDFDA-78A1-46AF-9085-001CCE3EDAC5 Q39412049-A46379DC-81CF-4B1C-BBD7-0B83B4CFF952 Q40408774-E58625E7-FAAA-4176-A4FE-5F3940E7C152 Q46265500-616050D8-835A-49B1-9064-96CC4E788FAA Q46589487-8DFD5946-DCF9-496E-BE6F-87AD892C2B14 Q48102085-46D34E8F-E4EE-4FF4-BA25-579F540228DC

P2860

High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates

http://www.wikidata.org/entity/Q33798166

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

High proportion of heteroresis ...... tuberculosis clinical isolates

@ast

High proportion of heteroresis ...... tuberculosis clinical isolates

@en

type

label

High proportion of heteroresis ...... tuberculosis clinical isolates

@ast

High proportion of heteroresis ...... tuberculosis clinical isolates

@en

prefLabel

High proportion of heteroresis ...... tuberculosis clinical isolates

@ast

High proportion of heteroresis ...... tuberculosis clinical isolates

@en

P1433

Q33798166-3B37F1D6-0D52-47B4-BFF8-3758B64E5889

P1476

Q33798166-F230B0B9-FB48-4A3A-BA3C-0B4C3F172076

P2093

Q33798166-08091E2A-42CD-4D46-B61A-28D9F4412E78

Q33798166-2E9B5608-F3E4-4EE0-B47B-458F38398A7E

Q33798166-96CBC723-4CAC-43CD-8C34-009424749087

Q33798166-AF75B028-14E6-4B54-BD2E-58829B9AE891

P2860

Q33798166-067217D2-1E71-4854-A791-615E44F54E6F

Q33798166-11925884-D19E-4654-BF00-4065EA788EED

Q33798166-1718FFFA-96F7-43C0-BB81-F736E4587800

Q33798166-1BF8CBF5-62D0-4316-8069-AFBA47347DB1

Q33798166-2839A331-3FEB-441A-940B-B856E9821CA7

Q33798166-2BECD923-8D88-4511-B60B-6DFB5964A873

Q33798166-3504F02C-8561-4641-A365-4CA0E5D572DD

Q33798166-359611AF-2332-4E86-81B2-85322C788525

Q33798166-3DF7D597-C554-428F-8072-2379543BC313

Q33798166-58FEB70D-1AA9-4AE8-AD31-56B0A85F83A9

P304

Q33798166-3C836166-AED2-4AA6-9B7A-984303C960F7

P31

Q33798166-E8FAE285-B06D-409B-B1EF-5D14B3F5B90D

P356

Q33798166-CA64A9AF-BCFF-4BEC-B21B-71AB3B8BC244

P407

Q33798166-43795C7F-DC6F-4F89-9D8B-B5E041FB3741

P433

Q33798166-4F375F2B-4E46-44E8-AD18-9726A845E12E

P478

Q33798166-C40CFE66-EBD2-45F6-98B4-AF926A40EE74

P50

Q33798166-0B85D6AE-7159-43BC-A270-B7300D56E56B

Q33798166-5BE8DE78-98B9-42BE-901A-A3F6FE8FC985

P577

Q33798166-2F6A893D-0AF3-4D9A-937F-9E620D292E77

P698

Q33798166-74B021E2-ED24-46C2-95D8-C337DA251F15

P921

Q33798166-46D8EC91-10D8-44A4-9760-D88E1409AA9B

P932

Q33798166-3A09C1B3-3EC5-4854-B2C9-80E544CFBEE6

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

High proportion of heteroresis ...... tuberculosis clinical isolates

@en

P2093

Amondrea Blackman

http://www.w3.org/2001/XMLSchema#string

Fernanda Maruri

http://www.w3.org/2001/XMLSchema#string

Miguel Herrera

http://www.w3.org/2001/XMLSchema#string

Timothy R Sterling

http://www.w3.org/2001/XMLSchema#string

P2860

High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology

The Sequence Alignment/Map format and SAMtools

Fast and accurate long-read alignment with Burrows-Wheeler transform

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3

Steps to ensure accuracy in genotype and SNP calling from Illumina sequencing data.

Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.

Evaluation of the analytical performance of the Xpert MTB/RIF assay.

Evaluation of the inaccurate assignment of mixed infections by Mycobacterium tuberculosis as exogenous reinfection and analysis of the potential role of bacterial factors in reinfection.

A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.

High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.

P304

3270-3275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02066-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

David C. Samuels

Brandon Eilertson

P577

2014-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24687490

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

4068501

http://www.w3.org/2001/XMLSchema#string